Forte Biosciences, Inc. [FBRX] - / argenx BV tender offer
Argentx BV, through Avena Merger Sub Inc., has launched a tender offer for Forte Biosciences, Inc. with an expiration date of August 26, 2026.
Why this matters
Forte Biosciences, Inc., a Delaware-incorporated company in the pharmaceutical preparations industry, focuses on developing treatments for dermatological conditions. Argenx BV, through its subsidiary Avena Merger Sub Inc., has initiated a tender offer to acquire Forte Biosciences, Inc., with the offer set to expire on August 26, 2026. The Agreement and Plan of Merger was signed on July 26, 2026, and includes a Tender and Support Agreement with certain Forte stockholders, indicating a strategic move by argenx BV to consolidate its position in the dermatological treatment market.